Table 3. Hazard Ratio for new onset type 2 DM (both group, N = 4044).
Crude Hazard Ratio (95% C.I.) | P-value | Adjusted Hazard Ratio* (95% C.I.) | P-value | |
---|---|---|---|---|
Alendronate exposure | ||||
Exposed | 1.00 | 1.00 | ||
Non-exposed | 1.20(1.03–1.41) | 0.0219 | 1.23(1.05–1.44) | 0.0123 |
Age | ||||
<65 | 1.00 | 1.00 | ||
≧65 | 1.03(0.89–1.19) | 0.7311 | 0.94(0.81–1.09) | 0.4008 |
Gender | ||||
Male | 1.00 | 1.00 | ||
Female | 1.12(0.95–1.32) | 0.1832 | 1.11(0.94–1.31) | 0.2155 |
Dyslipidemia | ||||
No | 1.00 | 1.00 | ||
Yes | 1.93(1.53–2.43) | <0.001 | 1.72(1.36–2.18) | <0.001 |
HTN | ||||
No | 1.00 | 1.00 | ||
Yes | 1.54(1.35–1.76) | <0.001 | 1.51(1.31–1.73) | <0.001 |
*Adjust for Age, Gender, dyslipidemia and HTN